Apr 24 |
BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates
|
Apr 24 |
BioMarin updated 2024 guidance sees EPS raise, but no change to revenue
|
Apr 24 |
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
|
Apr 24 |
BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11, revenue of $648.83M misses by $2.98M
|
Apr 24 |
BioMarin Reports Record Financial Results for the First Quarter 2024
|
Apr 23 |
BioMarin Pharmaceutical Q1 2024 Earnings Preview
|
Apr 23 |
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
|
Apr 23 |
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
|
Apr 22 |
BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says
|
Apr 22 |
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
|